Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck

Clinical trial NCT00725764 · COMPLETED

Trial details

NCT number: NCT00725764
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Head and Neck

Start date: 2007-08-27
Primary completion: 2009-05-02
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.